Status
Conditions
Treatments
About
The high price of electrocardiograph (ECG) devices - with most hospital-grade devices costing thousands of dollars - is one of the barriers to access of this vital technology. There is a shortage of ECG devices in underserved areas and the devices available on the market currently are not adequate to solve this problem. Our solution is a low-cost high-quality open-access ECG device. This study intends to validate the study ECG device in human patients by demonstrating equivalence between the study ECG device and a gold standard device.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Phase 1:
Phase 2:
Exclusion criteria
Phase 1:
Phase 2:
Primary purpose
Allocation
Interventional model
Masking
450 participants in 2 patient groups
Loading...
Central trial contact
Tarek Loubani, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal